NATCOPHARM — Natco Pharma Share News
0.000.00%
Last trade - 00:00- IN₹141.83bn
- IN₹120.26bn
- IN₹40.78bn
India's Natco Pharma dips after quarterly profit falls
Brief: Natco Pharma To Buy 51.6 Mln Shares Of Adcock Ingram
Brief: Adcock Ingram Says Natco Pharma To Buy All Eligible Shares Of Adcock Ingram
Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market
Brief: Natco Pharma Announces Conclusion Of US FDA Inspection
India's Natco Pharma slips after FDA 'observation' on facility
India's Natco Pharma gains after Q4 profit rise
Brief: Natco Pharma Prices Risdiplam At 15,900 Rupees MRP
Factbox: Lilly's weight-loss drug launch in India to energize rivals eyeing mega market
India's Natco Pharma plunges on weak quarterly earnings
India Stocks: India's benchmarks set to open higher as investors assess key data
Brief: Natco Pharma Dec-Quarter Consol Net Profit 1.33 Bln Rupees
Brief: Lupin And Natco Receive U.S. FDA Approval For Bosentan Tablets
Brief: Natco Pharma Announces Approval Of ANDA For Everolimus Tablets
Brief: Natco Pharma Gets Tax Penalty Demand Order Of 3.8 Mln Rupees
Brief: Natco Pharma Sells Land For 1.16 Billion Rupees
Brief: Natco Pharma Submits ANDA For Risdiplam For Oral Solution
Brief: Natco Pharma Sells Investment Held In ISCA, Inc For $2.1 Mln
Brief: Natco Pharma Says Sept-Quarter Consol Net Profit At 6.77 Billion Rupees